{
    "clinical_study": {
        "@rank": "156404", 
        "arm_group": [
            {
                "arm_group_label": "water-soluble therapy", 
                "arm_group_type": "Experimental", 
                "description": "The patient acted as their own control and the experimental and comparison arms (water-soluble therapy and silver sulfadiazine) were alternated on a daily basis"
            }, 
            {
                "arm_group_label": "silver sulfadiazine", 
                "arm_group_type": "Active Comparator", 
                "description": "The patient acted as their own control and the experimental and comparison arms (water-soluble therapy and silver sulfadiazine) were alternated on a daily basis"
            }
        ], 
        "brief_summary": {
            "textblock": "Partial thickness burns are a common, painful injury requiring a great deal of resources in\n      their care. Silver sulfadizine is a commonly-used topical antimicrobial, but is difficult to\n      remove due to its lipid base. We are comparing a water-based topical antimicrobial therapy\n      to silver sulfadiazine and hypothesize that the water-based therapy is superior in terms of\n      pain control and resources required to deliver care."
        }, 
        "brief_title": "Comparison of a Water-soluble Topical Antimicrobial to Silver Sulfadiazine in Partial Thickness Burns", 
        "completion_date": {
            "#text": "October 2011", 
            "@type": "Actual"
        }, 
        "condition": "Burn", 
        "condition_browse": {
            "mesh_term": "Burns"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  adult inpatients with partial thickness burns\n\n        Exclusion Criteria:\n\n          -  superficial or full thickness burns, facial burns, intubated or sedated, pediatric"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "8", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 17, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01926392", 
            "org_study_id": "15603"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "water-soluble therapy", 
                    "silver sulfadiazine"
                ], 
                "description": "The patient acted as their own control and the experimental and comparison arms (water-soluble therapy and silver sulfadiazine) were alternated on a daily basis", 
                "intervention_name": "water-soluble therapy", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "water-soluble therapy", 
                    "silver sulfadiazine"
                ], 
                "description": "The patient acted as their own control and the experimental and comparison arms (water-soluble therapy and silver sulfadiazine) were alternated on a daily basis", 
                "intervention_name": "silver sulfadiazine", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Anti-Infective Agents", 
                "Silver Sulfadiazine", 
                "Sulfadiazine"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "August 20, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Charlottesville", 
                    "country": "United States", 
                    "state": "Virginia", 
                    "zip": "22908"
                }, 
                "name": "University of Virginia Health System"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Prospective Randomized Trial Comparing Silver Sulfadiazine Cream to a Water-Soluble Poly-Antimicrobial Gel in Partial Thickness Burn Wounds", 
        "other_outcome": {
            "description": "All narcotics given for premedication and during the dressing change will be converted to their morphine-equivalent and totaled", 
            "measure": "narcotic medication administered", 
            "safety_issue": "No", 
            "time_frame": "180 minutes"
        }, 
        "overall_official": {
            "affiliation": "University of Virginia", 
            "last_name": "Jonathan Black, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "October 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Pain is assessed on a 0-10 point scale using both the patient's reported value and correlating with the value derived from nursing assessment using the visual analog scale. This is recorded at defined time points before, during, and after the dressing change", 
            "measure": "Pain level", 
            "safety_issue": "No", 
            "time_frame": "180 minutes"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01926392"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "The time to perform the dressing change in total and for various steps is recorded in minutes.", 
            "measure": "time to perform dressing changes", 
            "safety_issue": "No", 
            "time_frame": "up to 180 minutes"
        }, 
        "source": "University of Virginia", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Virginia", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2011", 
        "study_design": "Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}